Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First Prospective, Single-arm, Multicentre Study to Evaluate the Safety and Efficacy of the Overall Thrombectomy System for Stroke: iNedit, iNdeep and iNtercept in Patients With Acute Ischemic Stroke.

NCT05893719 is registered in ClinicalTrials.gov with iVascular S.L.U. as lead sponsor.

NCT NCT05893719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05893719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First Prospective, Single-arm, Multicentre Study to Evaluate the Safety and Efficacy of the Overall Thrombectomy System for Stroke: iNedit, iNdeep and iNtercept in Patients With Acute Ischemic Stroke.
Lead sponsor
iVascular S.L.U.
Phase
Observational
Overall status
Completed
Start date
July 29, 2022
Completion date
February 25, 2025
Enrollment
175 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke